Cervical screening has long been a vital tool in preventing cervical cancer, helping to detect abnormal changes in the cervix before they develop into cancer. Currently, the test relies on collecting cells from the cervix via a smear, which, while effective, can be uncomfortable for some.
Recent scientific advances suggest that, in the future, cervical screening may be possible through a simple test of blood collected during menstruation. Researchers are exploring ways to detect signs of human papillomavirus (HPV), the virus that can cause cervical cancer, in menstrual (period) blood. If successful, this could revolutionise screening by making it less invasive and potentially increasing participation among those who currently avoid smear tests due to discomfort or anxiety.
While this prospect is promising, it remains in the early stages of research. Blood-based screening will need rigorous testing to ensure it is as accurate and reliable as the current cervical smear. Until then, traditional cervical screening remains the gold standard for early detection and prevention.
It is therefore important for anyone with a cervix to continue to attend regular cervical screening appointments when invited.
Even if you have had a normal smear result, it is essential to seek medical advice promptly if you experience any unusual symptoms such as unexplained bleeding, pelvic pain, or changes in discharge. Early investigation can make a significant difference to outcomes.
If you or someone you care about has been affected by a delayed diagnosis of cervical cancer, please get in touch.r.
"*" indicates required fields